Reynoutria multiflora

Ethnobotanical Studies

Studies

Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest.

Summary

PM, a traditional Chinese medicine, shows potential as a treatment for prostate cancer by suppressing cancer growth in an AR-dependent manner. This study investigates its anti-tumor mechanism in advanced prostate cancer.

Zhou Q et al (2024).
Bioorg Chem.
PubMed:
39180863

Processing of Reynoutria multiflora: transformation of catechin and gallic acid derivatives and their identification.

Bai J et al (2024).
Front Pharmacol.
PubMed:
38469408

Alleviation of Glucocorticoid-Induced Osteoporosis in Rats by Ethanolic Reynoutria multiflora (Thunb.) Moldenke Extract.

Liu Y et al (2024).
J Med Food.
PubMed:
38442325

Identification and localization of morphological feature-specific metabolites in Reynoutria multiflora roots.

Cai MT et al (2023).
Phytochemistry.
PubMed:
36460140

Integrated spatially resolved metabolomics and network toxicology to investigate the hepatotoxicity mechanisms of component D of Polygonum multiflorum Thunb.

Jiang HY et al (2022).
J Ethnopharmacol.
PubMed:
35987407

Transformation of Stilbene Glucosides From Reynoutria multiflora During Processing.

Bai J et al (2022).
Front Pharmacol.
PubMed:
35548344

Beware of the Potential Risks for Polygoni Multiflori Caulis-Induced Liver Injury.

Kong WS et al (2022).
Front Pharmacol.
PubMed:
35431961

Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics.

Review
Zhai XR et al (2021).
Front Pharmacol.
PubMed:
34539416

Screening of Quality Markers During the Processing of Reynoutria multiflora Based on the UHPLC-Q-Exactive Plus Orbitrap MS/MS Metabolomic Method.

Bai J et al (2021).
Front Pharmacol.
PubMed:
34456722

Lipidomics Analysis Indicates Disturbed Hepatocellular Lipid Metabolism in Reynoutria multiflora-Induced Idiosyncratic Liver Injury.

Wu X et al (2020).
Front Pharmacol.
PubMed:
33408629

Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells.

Yang N et al (2019).
Front Pharmacol.
PubMed:
31297058

Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats.

Tu C et al (2019).
Front Pharmacol.
PubMed:
31024306